Mycophenolate mofetil in a case of relapsed, refractory thrombotic thrombocytopenic purpura.
A case of relapsing and refractory thrombotic thrombocytopenic purpura received mycophenolate mofetil (MMF) to attempt to maintain remission. The possible use of MMF in thrombotic thrombocytopenic purpura is discussed.
Ahmad
Humayun N
HN
Department of Haematology, Guys and St Thomas NHS Foundation Trust, London, UK.
Thomas-Dewing
Rowena R
RR
Hunt
Beverley J
BJ
D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid